Last updated on June 2018

Triglycerides between 500 and 2,000


Brief description of study

A phase3, multi-center, placebo-controlled, randomized, double-blind, 12-week study with a 40-week, active-controlled, double-blind extension to evaluate the efficacy and safety of an investigational medication in adult patients with fasting triglyceride levels greater than or equal to 500mg/dL and less than 2,000 mg/dL and Normal or Impaired renal function.

Eligibility Criteria:

Men and women, ages 18 years or older, will take part in this study who have high triglycerides (a type of fat found in your blood).

Other Details:

Study Schedule: Participation may last approximately 61 weeks which will include about 11 visits to the clinic.

Cost: You (and/or your insurance company) will not be expected to pay for any of the study procedures. Also, you (and/or your insurance company) will not be expected to pay for the study drugs or tests that are part of this research study.

Compensation for Participation: If you complete all study visits you will receive up to a total of $550.00.

Clinical Study Identifier: TX133456

Contact Investigators or Research Sites near you

Start Over
Sorry. There are no research Sites conducting this study in the radius provided. ( View all Sites )